SurgRx Raises Series G

SurgRx Inc., a Redwood City, Calif.-based developer of laparoscopic vessel fusion tools for surgical hemostasis, has raised around $20 million in Series G funding, according to a February regulatory filing. The company has now raised around $83 million in total VC funding since 2003, from firms like Alta Partners, New Enterprise Associates, California Technology Ventures, Magnetar Capital Return, Prospect Venture Partners and Trellis Health Ventures. www.surgrx.com